Literature DB >> 8616837

Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.

U Hamann1, C Herbold, S Costa, E F Solomayer, M Kaufmann, G Bastert, H U Ulmer, H Frenzel, D Komitowski.   

Abstract

Recently, the breast cancer susceptibility gene BRCA2 has been identified in chromosome 13q, a region that also contains the retinoblastoma gene RB1. To elucidate a possible role of BRCA2 and RB1 in sporadic breast tumorigenesis, allelic imbalance (AI) at 13q loci was examined in 78 primary sporadic breast tumors. AI was found in 52-63% of tumors. Nine tumors showed AI only in the BRCA2 region but not at RB1. Six tumors showed AI at RB1 but not in the BRCA2 region. AI in the BRCA2 region correlated significantly with aneuploidy (P = 0.032) and AI at RB1 with small tumor size (P = 0.025). Our data suggest that BRCA2 and RB1 may be both distinct target loci for AI on chromosome 13 in sporadic breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616837

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  BRCA1 and BRCA2 proteins: roles in health and disease.

Authors:  J A Duncan; J R Reeves; T G Cooke
Journal:  Mol Pathol       Date:  1998-10

2.  Linkage mapping of rat Rb1 gene on chromosome 15.

Authors:  S Yamada; H Nakagama; M Toyota; T Ushijima; K Sato; T Sugimura; M Nagao
Journal:  Mamm Genome       Date:  1997-06       Impact factor: 2.957

3.  A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.

Authors:  D P O'Connor; E W Kay; M Leader; G M Murphy; G J Atkins; M J Mabruk
Journal:  Mol Pathol       Date:  2001-06

4.  Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.

Authors:  C Washington; F Dalbègue; F Abreo; J K Taubenberger; J H Lichy
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Core module biomarker identification with network exploration for breast cancer metastasis.

Authors:  Ruoting Yang; Bernie J Daigle; Linda R Petzold; Francis J Doyle
Journal:  BMC Bioinformatics       Date:  2012-01-18       Impact factor: 3.169

6.  Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.

Authors:  I Bièche; C Noguès; S Rivoilan; A Khodja; A Latil; R Lidereau
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.

Authors:  S Staff; J J Isola; O Johannsson; A Borg; M M Tanner
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

Review 8.  Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  BMC Syst Biol       Date:  2015-09-21

9.  Germline BRCA2 mutation in a case of aggressive prostate cancer accompanied by spinal bulbar muscular atrophy.

Authors:  Hiroshi Hongo; Takeo Kosaka; Hideyuki Hayashi; Kohei Nakamura; Hiroshi Nishihara; Shuji Mikami; Himisha Beltran; Mototsugu Oya
Journal:  Asian J Androl       Date:  2022 Jan-Feb       Impact factor: 3.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.